Table 5 Comparison of literature on pelvic chondrosarcoma
Author | Years of study | Number of patient | Patholy subtype | Pathology grade | Followup (year) | Local recurrence(%) | Surgical margin | Overall survival | Risk factors for OS |
|---|---|---|---|---|---|---|---|---|---|
Bus et al. [20] | 1985 to 2013 | 162 | Conventional primary central | 1(n = 30),2(n = 93),3(n = 39) | 12.6 (median) | 38% | Wide 51%;marginal 26%;intralesional 23% | 59% | Tumor grade,resection margins,tumor size,soft-tissue infiltration |
Stihsen et al. [22] | 1967 to 2012 | 58 | conventional (n = 46),dedifferentialted (n = 12) | 1(n = 11),2(n = 22),3(n = 13),dedifferentiated (n = 12) | 13 (mean) | 19% | Wide 73%, marginal 17%, intralesional 10% | 55% (5-yr) | Tumor grade, age, local recurrence |
Donati et al. [9] | 1971 to 1999 | 124 | Conventional | 1 (n = 1),2(n = 44),3(n = 18) | NA | 18% | Wide 65%, marginal+intralesional 35% | 92% (5-yr) | Tumor grade, tumor location (central/peripheral),type of operation (limb-sparing resection/hemipelvectomy),local recurrence |
Mavrogenis et al. [7] | 1975 to 2008 | 215 | Conventional (n = 119),secondary peripheral (n = 85), not specified (n = 9),periosteal (n = 2) | 1(n = 58),2(n = 105),3(n = 20),dedifferentiated (n = 32) | 8.6 (mean) | 30% | Wide 70%;marginal 13%;intralesional 17% | 83%(5-yr) | Tumor grade |
Ozaki et al. [19] | 1970 to 1993 | 31 | Primary (n = 23), secondary (n = 8) | NA | 5 (median) | 45% | Wide 26%;marginal 23%;intralesional 51% | 67.7%(5-yr) | Tumor type |
Deloin et al. [21] | 1968 to 2003 | 59 | Primary (n = 47), secondary (n = 12)/conventional(n = 52),dedifferentiated (n = 7) | 1(n = 11),2(n = 36),3(n = 5),dedifferentiated (n = 7) | 7.8 (mean) | 31% | Wide 78%;marginal 3%;intralesional 19% | 66%(5-yr) | Resection margin, tumor grade, acetabular involvement |
Wirbel et al. [15] | 1978 to 1998 | 51 | NA | NA | 6.2 (mean) | 20.40% | Wide 53%;marginal 31%;intralesional 16% | 58% | Tumor stage, resection margin |
Sheth et al. [23] | 1970 to 1992 | 67 | Conventional (n = 54),dedifferentialted (n = 13) | 1(n = 19),2(n = 18),3(n = 17),dedifferentiated (n = 13) | 9.6(median) | 28% | Negative 57%, positive 43% | 52% | Tumor grade |
Guo et al. [24] | 1998 to 2007 | 45 | Conventional (n = 32),dedifferentialted (n = 9), mesenchymal(n = 4) | NA | 3.1 (median) | 22.20% | Wide 77%;marginal 7%;intralesional 16% | 62.6% (5-yr) | NA |
Pring et al. [8] | 1975 to 1996 | 64 | Conventional (n = 57), dedifferentiated (n = 7)/primary (n = 49), secondary (n = 15) | 1(n = 33),2(n = 23),3(n = 1),dedifferentiated (n = 7) | 11.7 (median) | 19% | Wide 63%;marginal 20%;intralesional 17% | 82% (5-yr) | Tumor grade |
Current study | 2006 to 2018 | 80 | Conventional/ primary (n = 54), secondary (n = 26) | I (n = 11),II(n = 57),III(n = 12) | 3.3 (median) | 37.2% | Wide 63%;marginal 20%;intralesional 17% | 67.7%(5-yr) | Tumor grade |